D1-D2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms

Molecular Pharmacology

Volumn 84, Issue 2, 2013, Pages 190-200

  Chun, Lani S ^a,b   Free, R Benjamin ^a   Doyle, Trevor B ^a   Huang, Xi Ping ^c   Rankin, Michele L ^a   Sibley, David R ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; CHOLERA TOXIN; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN RECEPTOR KINASE 2; PERTUSSIS TOXIN; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; CALCIUM; DOPAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND; SK&F 83959; DRUG DERIVATIVE;

ARTICLE; CALCIUM ANTAGONISM; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; AGONISTS; ANALOGS AND DERIVATIVES; CELL LINE; DRUG EFFECTS; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; CELL STRAIN HEK293; DRUG EFFECT; DRUG POTENTIATION;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; CALCIUM; CALCIUM SIGNALING; CELL LINE; DOPAMINE; GTP-BINDING PROTEINS; HEK293 CELLS; HUMANS; LIGANDS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 84880591671     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.113.085175     Document Type: Article

References (70)

1. Aizman O, Brismar H, Uhlén P, Zettergren E, Levey AI, Forssberg H, Greengard P, and Aperia A (2000) Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nat Neurosci 3:226-230.
2. Allen JA, Halverson-Tamboli RA, and Rasenick MM (2007) Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci 8:128-140.
3. Andringa G, Stoof JC, and Cools AR (1999) Sub-chronic administration of the dopamine D(1) antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: stable therapeutic effects and wearing-off dyskinesia. Psychopharmacology (Berl) 146:328-334.
4. Ariano MA, Larson ER, Noblett KL, Sibley DR, and Levine MS (1997) Coexpression of striatal dopamine receptor subtypes and excitatory amino acid subunits. Synapse 26:400-414.
5. Beaulieu J-M and Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63:182-217.
6. Bertran-Gonzalez J, Bosch C, Maroteaux M, Matamales M, Hervé D, Valjent E, and Girault J-A (2008) Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 28:5671-5685.
7. Björk K and Svenningsson P (2011) Modulation of monoamine receptors by adaptor proteins and lipid rafts: role in some effects of centrally acting drugs and therapeutic agents. Annu Rev Pharmacol Toxicol 51:211-242.
8. Camps M, Hou C, Sidiropoulos D, Stock JB, Jakobs KH, and Gierschik P (1992) Stimulation of phospholipase C by guanine-nucleotide-binding protein β γ subunits. Eur J Biochem 206:821-831.
9. Carman CV, Parent J-L, Day PW, Pronin AN, Sternweis PM, Wedegaertner PB, Gilman AG, Benovic JL, and Kozasa T (1999) Selective regulation of Galpha(q/11) by an RGS domain in the G protein-coupled receptor kinase, GRK2. J Biol Chem 274:34483-34492.
10. Carroll RC, Morielli AD, and Peralta EG (1995) Coincidence detection at the level of phospholipase C activation mediated by the m4 muscarinic acetylcholine receptor. Curr Biol 5:536-544.
11. Celver J, Sharma M, and Kovoor A (2012) D(2)-Dopamine receptors target regulator of G protein signaling 9-2 to detergent-resistant membrane fractions. J Neurochem 120:56-69.
12. Cools AR, Lubbers L, van Oosten RV, and Andringa G (2002) SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals? Neuropharmacology 42:237-245.
13. Dziedzicka-Wasylewska M, Faron-Górecka A, Andrecka J, Polit A, Kuśmider M, and Wasylewski Z (2006) Fluorescence studies reveal heterodimerization of dopamine D1 and D2 receptors in the plasma membrane. Biochemistry 45: 8751-8759.
14. Ferré S, Baler R, Bouvier M, Caron MG, Devi LA, Durroux T, Fuxe K, George SR, Javitch JA, and Lohse MJ et al. (2009) Building a new conceptual framework for receptor heteromers. Nat Chem Biol 5:131-134.
15. Freedman NJ, Liggett SB, Drachman DE, Pei G, Caron MG, and Lefkowitz RJ (1995) Phosphorylation and desensitization of the human beta 1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase. J Biol Chem 270:17953-17961.
16. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, Jr, and Sibley DR (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429-1432.
17. 4 receptors modulates melatonin synthesis and release in the pineal gland. PLoS Biol 10:e1001347.
18. Guo L, Zhao J, Jin G, Zhao B, Wang G, Zhang A, and Zhen X. (2013). SKF83959 is a potent allosteric modulator of sigma-1 receptor. Mol Pharmacol 83:577-586.
19. Hasbi A, Fan T, Alijaniaram M, Nguyen T, Perreault ML, O'Dowd BF, and George SR (2009) Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc Natl Acad Sci USA 106: 21377-21382.
20. Hasbi A, O'Dowd BF, and George SR (2011) Dopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance. Mol Brain 4:26.
21. Hersch SM, Ciliax BJ, Gutekunst CA, Rees HD, Heilman CJ, Yung KK, Bolam JP, Ince E, Yi H, and Levey AI (1995) Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci 15:5222-5237.
22. Kendall RT and Senogles SE (2011) Isoform-specific uncoupling of the D2 dopamine receptors subtypes. Neuropharmacology 60:336-342.
23. Kern A, Albarran-Zeckler R, Walsh HE, and Smith RG (2012) Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron 73:317-332.
24. Koch WJ, Hawes BE, Inglese J, Luttrell LM, and Lefkowitz RJ (1994) Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates G beta gamma-mediated signaling. J Biol Chem 269:6193-6197.
25. Kong MMC, Verma V, O'Dowd BF, and George SR (2011) The role of palmitoylation in directing dopamine D1 receptor internalization through selective endocytic routes. Biochem Biophys Res Commun 405:445-449.
26. Korade Z and Kenworthy AK (2008) Lipid rafts, cholesterol, and the brain. Neuropharmacology 55:1265-1273.
27. Lee SP, So CH, Rashid AJ, Varghese G, Cheng R, Lança AJ, O'Dowd BF, and George SR (2004) Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 279:35671-35678.
28. Le Moine C and Bloch B (1995) D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol 355:418-426.
29. Le Moine C, Normand E, and Bloch B (1991) Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc Natl Acad Sci USA 88:4205-4209.
30. Lester J, Fink S, Aronin N, and DiFiglia M (1993) Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neurons. Brain Res 621:106-110.
31. Liu YF, Civelli O, Zhou QY, and Albert PR (1992) Cholera toxin-sensitive 39,59-cyclic adenosine monophosphate and calcium signals of the human dopamine-D1 receptor: selective potentiation by protein kinase A. Mol Endocrinol 6:1815-1824.
32. Łukasiewicz S, Faron-Górecka A, Dobrucki J, Polit A, and Dziedzicka-Wasylewska M (2009) Studies on the role of the receptor protein motifs possibly involved in electrostatic interactions on the dopamine D1 and D2 receptor oligomerization. FEBS J 276:760-775.
33. Mahan LC, Burch RM, Monsma FJ, Jr, and Sibley DR (1990) Expression of striatal D1 dopamine receptors coupled to inositol phosphate production and Ca2+ mobilization in Xenopus oocytes. Proc Natl Acad Sci USA 87:2196-2200.
34. 3 receptors. Mol Pharmacol 79:91-105.
35. Millan MJ, Newman-Tancredi A, Quentric Y, and Cussac D (2001) The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors. Psychopharmacology (Berl) 156:58-62.
36. Milligan G (2004) G protein-coupled receptor dimerization: function and ligand pharmacology. Mol Pharmacol 66:1-7.
37. Missale C, Nash SR, Robinson SW, Jaber M, and Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78:189-225.
38. Missale C, Fiorentini C, Collo G, and Spano P (2010) The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes. J Recept Signal Transduct Res 30:347-354.
39. Monsma FJ, Jr, Mahan LC, McVittie LD, Gerfen CR, and Sibley DR (1990) Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc Natl Acad Sci USA 87:6723-6727.
40. Namkung Y, Dipace C, Javitch JA, and Sibley DR (2009) G protein-coupled receptor kinase-mediated phosphorylation regulates post-endocytic trafficking of the D2 dopamine receptor. J Biol Chem 284:15038-15051.
41. Ng J, Rashid AJ, So CH, O'Dowd BF, and George SR (2010) Activation of calcium/calmodulin-dependent protein kinase IIalpha in the striatum by the heteromeric D1-D2 dopamine receptor complex. Neuroscience 165:535-541.
42. O'Dowd BF, Ji X, Alijaniaram M, Rajaram RD, Kong MMC, Rashid A, Nguyen T, and George SR (2005) Dopamine receptor oligomerization visualized in living cells. J Biol Chem 280:37225-37235.
43. O'Dowd BF, Ji X, Nguyen T, and George SR (2012) Two amino acids in each of D1 and D2 dopamine receptor cytoplasmic regions are involved in D1-D2 heteromer formation. Biochem Biophys Res Commun 417:23-28.
44. Okajima F, Sato K, Sho K, and Kondo Y (1989) Stimulation of adenosine receptor enhances a 1-adrenergic receptor-mediated activation of phospholipase C and Ca2+ mobilization in a pertussis toxin-sensitive manner in FRTL-5 thyroid cells. FEBS Lett 248:145-149.
45. O'Sullivan GJ, Roth BL, Kinsella A, and Waddington JL (2004) SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography. Eur J Pharmacol 486:273-280.
46. Pacheco MA and Jope RS (1997) Comparison of [3H]phosphatidylinositol and [3H] phosphatidylinositol 4,5-bisphosphate hydrolysis in postmortem human brain membranes and characterization of stimulation by dopamine D1 receptors. J Neurochem 69:639-644.
47. Panchalingam S and Undie AS (2001) SKF83959 exhibits biochemical agonism by stimulating [(35)S]GTP gamma S binding and phosphoinositide hydrolysis in rat and monkey brain. Neuropharmacology 40:826-837.
48. Pei L, Li S, Wang M, Diwan M, Anisman H, Fletcher PJ, Nobrega JN, and Liu F (2010) Uncoupling the dopamine D1-D2 receptor complex exerts antidepressantlike effects. Nat Med 16:1393-1395.
49. Perreault ML, Fan T, Alijaniaram M, O'Dowd BF, and George SR (2012b) Dopamine D1-D2 receptor heteromer in dual phenotype GABA/glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2. PLoS ONE 7:e33348.
50. Perreault ML, Hasbi A, Alijaniaram M, Fan T, Varghese G, Fletcher PJ, Seeman P, O'Dowd BF, and George SR (2010) The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia. J Biol Chem 285:36625-36634.
51. Perreault ML, Hasbi A, Alijaniaram M, O'Dowd BF, and George SR (2012a) Reduced striatal dopamine D1-D2 receptor heteromer expression and behavioural subsensitivity in juvenile rats. Neuroscience 225:130-139.
52. Perreault ML, Hasbi A, O'Dowd BF, and George SR. (2011). The dopamine D1-D2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in basal ganglia. Front Neuroanat 5:31.
53. Prinster SC, Hague C, and Hall RA (2005) Heterodimerization of g protein-coupled receptors: specificity and functional significance. Pharmacol Rev 57:289-298.
54. Rashid AJ, O'Dowd BF, Verma V, and George SR (2007b) Neuronal Gq/11-coupled dopamine receptors: an uncharted role for dopamine. Trends Pharmacol Sci 28: 551-555.
55. Rashid AJ, So CH, Kong MMC, Furtak T, El-Ghundi M, Cheng R, O'Dowd BF, and George SR (2007a) D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci USA 104:654-659.
56. Rebres RA, Roach TIA, Fraser IDC, Philip F, Moon C, Lin K-M, Liu J, Santat L, Cheadle L, and Ross EM et al. (2011) Synergistic Ca2+ responses by Gai-and Gaqcoupled G-protein-coupled receptors require a single PLCb isoform that is sensitive to both Gbg and Gaq. J Biol Chem 286:942-951.
57. Schetz JA and Sibley DR (2001) The binding-site crevice of the D4 dopamine receptor is coupled to three distinct sites of allosteric modulation. J Pharmacol Exp Ther 296:359-363.
58. Sebastião AM, Assaife-Lopes N, Diógenes MJ, Vaz SH, and Ribeiro JA (2011) Modulation of brain-derived neurotrophic factor (BDNF) actions in the nervous system by adenosine A(2A) receptors and the role of lipid rafts. Biochim Biophys Acta 1808:1340-1349.
59. Seeman P and Van Tol HHM (1993) Dopamine D4 receptors bind inactive (1)-aporphines, suggesting neuroleptic role: sulpiride not stereoselective. Eur J Pharmacol 233:173-174.
60. Sibley DR and Monsma FJ, Jr (1992) Molecular biology of dopamine receptors. Trends Pharmacol Sci 13:61-69.
61. So CH, Varghese G, Curley KJ, Kong MMC, Alijaniaram M, Ji X, Nguyen T, O'dowd BF, and George SR (2005) D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor. Mol Pharmacol 68: 568-578.
62. Surmeier DJ, Eberwine J, Wilson CJ, Cao Y, Stefani A, and Kitai ST (1992) Dopamine receptor subtypes colocalize in rat striatonigral neurons. Proc Natl Acad Sci USA 89:10178-10182.
63. Surmeier DJ, Song W-J, and Yan Z (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci 16:6579-6591.
64. Takebe Y, Seiki M, Fujisawa J, Hoy P, Yokota K, Arai K, Yoshida M, and Arai N (1988) SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol 8: 466-472.
65. Terrillon S and Bouvier M (2004) Roles of G-protein-coupled receptor dimerization. EMBO Rep 5:30-34.
66. Toms NJ and Roberts PJ (1999) Group 1 mGlu receptors elevate [Ca2+]i in rat cultured cortical type 2 astrocytes: [Ca2+]i synergy with adenosine A1 receptors. Neuropharmacology 38:1511-1517.
67. Undie AS and Friedman E (1990) Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. J Pharmacol Exp Ther 253:987-992.
68. Wang HY, Undie AS, and Friedman E (1995) Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Mol Pharmacol 48:988-994.
69. Zhang LJ, Lachowicz JE, and Sibley DR (1994) The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells. Mol Pharmacol 45:878-889.
70. Zhang Z-J, Jiang X-L, Zhang SE, Hough CJ, Li H, Chen J-G, and Zhen X-C (2005) The paradoxical effects of SKF83959, a novel dopamine D1-like receptor agonist, in the rat acoustic startle reflex paradigm. Neurosci Lett 382:134-138.